Full name
DOBRY LEK SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ SPÓŁKA KOMANDYTOWA
uses securityreCAPTCHA
47.73.Z - Retail sale of pharmaceutical products
21.10.Z - Manufacture of basic pharmaceutical products
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
32.50.Z - Production of medical devices, instruments, and products, including dental products
32.99.Z - Production of other products not classified elsewhere
47.29.Z - Retail trade
47.74.Z - Retail sale of medical and orthopedic products
47.75.Z - Retail sale of cosmetics and toiletries
47.91.Z - Intermediary retail sale, non-specialized
47.99.Z - Retail trade
2022 | 2023 | 2024 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Profit (loss) on sale | 1,3 | 1,1 | 1 | -12,1 |
Gross profit (loss) | 1,3 | 1,1 | 1,2 | 11,6 |
EBITDA | 1,3 | 1,1 | 1,3 | 13,5 |
Short time liabilities | 1,3 | 2,5 | 4,2 | 71,2 |
Other operating costs | 0,1 | 0,1 | 0 | -99,5 |
Equity capital | 1,1 | 0,9 | 0,3 | -65,8 |
Operating profit (EBIT) | 1,3 | 1,1 | 1,3 | 14,1 |
Assets | 2,4 | 3,4 | 4,5 | 34,9 |
Net profit (loss) | 1 | 0,8 | 1 | 14,5 |
Cash | 0,3 | 0,4 | 0,1 | -65,2 |
Net income from sale | 12,9 | 17 | 27,2 | 60,3 |
Liabilities and provisions for liabilities | 1,4 | 2,5 | 4,2 | 71,2 |
Working assets | 2,2 | 3,2 | 4,3 | 36,9 |
Other income costs | 0,1 | 0,1 | 0,3 | 265,1 |
Depreciation | 0 | 0 | 0 | -10,5 |
% | % | % | p.p. | |
Profitability of capital | 95,3 | 92,9 | 311,5 | 218,6 |
Equity capital to total assets | 43,6 | 26,5 | 6,7 | -19,8 |
Gross profit margin | 9,9 | 6,2 | 4,3 | -1,9 |
EBITDA Margin | 10,2 | 6,6 | 4,7 | -1,9 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 37 | 53 | 57 | 4 |
Current financial liquidity indicator | 1.687469482421875 | 1.2770050764083862 | 1.0213476419448853 | -0,3 |
Net dept to EBITDA | -0.07389191538095474 | -0.19515442848205566 | -0.01817440800368786 | 0,2 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane